Archived
COGR Testimony at NIH Hearings on March-in Rights
NIH has denied the request from Essential Inventions, Inc. to exercise march-in rights under The Bayh-Dole Act in connection with the pricing of Norvir, marketed by Abbott Laboratories for the treatment of patients with HIV/AIDS. The decision and related materials are available online.
NPRM Public Comments Overview
The document provides a comprehensive summary of public feedback on the Notice of Proposed Rulemaking (NPRM) as of May 2016, focusing on proposed revisions to the Common Rule governing human subjects research. Over 2,100 comments were received, significantly outpacing responses to the earlier Advance Notice of Proposed Rulemaking in 2011. Most responses were submitted by individuals, many of whom
